August 29, 2017
VBL Therapeutics to Present at the Rodman & Renshaw Global Investment Conference in New York on September 10-12, 2017

TEL AVIV, Israel, Aug. 28, 2017 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced it will provide a corporate overview at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.  The conference is being held on September 10-12, 2017 at Lotte New York Palace Hotel in New York City.

Presentation Details:

Date:  Monday, September 11, 2017

Time:  2:35-3:00 PM Eastern Time

Location:  Holmes II; Lotte New York Palace Hotel in New York City